COVID-19 Impact on Fisher & Paykel Healthcare Corporation Limited's Revenue and Operations (Medical Devices)
Summary
Fisher & Paykel Healthcare Corporation Limited (Fisher & Paykel) designs, manufactures and commercializes products and systems for use in acute care, respiratory care, and obstructive sleep apnea. Headquartered in New Zealand with global manufacturing and sales reach. Fisher & Paykel's product range include breathing circuits, chambers, continuous positive airway pressure devices, humidifiers, infant resuscitators, infant warmers, interfaces, masks, nasal cannula, software and data management, surgical devices, and accessories for neonatal care and adult patient care. The report, COVID-19 Impact on Fisher & Paykel Healthcare Corporation Limited's Revenue and Operations (Medical Devices) presents a deep dive analysis into how Fisher & Paykel Healthcare Corporation Limited is placed to respond to the COVID-19 crisis, by examining its sector performance and competitiveness.
Deep dive analysis into how Fisher & Paykel Healthcare Corporation Limited is placed to respond to the COVID-19 crisis, by examining its sector performance and competitiveness.
Key Highlights
Scope
The report provides a comprehensive analysis of the impact of COVID-19 on Fisher & Paykel Healthcare Corporation Limited -
Reasons to Buy
Summary
Fisher & Paykel Healthcare Corporation Limited (Fisher & Paykel) designs, manufactures and commercializes products and systems for use in acute care, respiratory care, and obstructive sleep apnea. Headquartered in New Zealand with global manufacturing and sales reach. Fisher & Paykel's product range include breathing circuits, chambers, continuous positive airway pressure devices, humidifiers, infant resuscitators, infant warmers, interfaces, masks, nasal cannula, software and data management, surgical devices, and accessories for neonatal care and adult patient care. The report, COVID-19 Impact on Fisher & Paykel Healthcare Corporation Limited's Revenue and Operations (Medical Devices) presents a deep dive analysis into how Fisher & Paykel Healthcare Corporation Limited is placed to respond to the COVID-19 crisis, by examining its sector performance and competitiveness.
Deep dive analysis into how Fisher & Paykel Healthcare Corporation Limited is placed to respond to the COVID-19 crisis, by examining its sector performance and competitiveness.
Key Highlights
- Fisher & Paykel’s multiple efforts to support hospitals and patients affected by COVID-19 has contributed to order intake for the first quarter 2020 being higher than expected by the market.
- Fisher & Paykel has seen an increased global demand for ventilators for intensive care units since the outbreak of the COVID-19 pandemic.
- Inspite of the heavy impact in Europe and rapid rise of COVID-19 cases in the US, the general outlook for sales has a significantly positive outlook.
Scope
The report provides a comprehensive analysis of the impact of COVID-19 on Fisher & Paykel Healthcare Corporation Limited -
- It provides insights on Fisher & Paykel Healthcare Corporation Limited's exposure to the regions and businesses impacted by the COVID-19 outbreak.
- It offers an overview of the company’s revenue impact by region and market for 2020 due to the COVID-19 outbreak.
Reasons to Buy
- An overview of how Fisher & Paykel Healthcare Corporation Limited will be affected by the COVID-19 pandemic.
Table of Contents
COVID-19 impact analysis on Edwards Lifesciences Corp - Key Findings- Edwards Lifesciences Corp. Key Facts
- Geographic spread analysis - COVID-19 vs Edwards Lifesciences Corp. sales
- The impact of COVID-19 on regional GDP per capita levels
- Edwards Lifesciences Corp. exposure: revenues by region and market vs regional impact levels
- Edwards Lifesciences : revenue impact by region and market for 2020
- Operational reactions from Edward Lifesciences? Indications from recruitment trends
- Operational reactions from Edwards’ Indications from US pricing trends
- Contact
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Edwards Lifesciences Corp.
